RhyGaze logo

RhyGaze

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$86M


RhyGaze is a biotechnology company developing gene therapies for vision restoration in retinal diseases.

Total Funding

$86M

Headquarters

Basel, Switzerland

Founded

N/A

Focus Areas

Gene therapy
Retinal diseases
Vision restoration
Clinical trials
Biotechnology

Investors

GV logo
BioGeneration Ventures logo
F-Prime Capital logo
Novartis logo
Arch Venture Partners logo